Status:
COMPLETED
LifeBio Memory Digital Reminiscence Platform
Lead Sponsor:
Benjamin Rose Institute on Aging
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Dementia
Cognitive Impairment
Eligibility:
All Genders
18-112 years
Phase:
NA
Brief Summary
Non-pharmacological interventions and person-centered care strategies are important elements of care for people with Alzheimer's disease and related dementias. Life story work, which uses written and ...
Detailed Description
This project offers the unique and timely opportunity to evaluate the feasibility, acceptability, and efficacy of LifeBio Memory's effectiveness as a solution for improving quality of life and quality...
Eligibility Criteria
Inclusion
- Inclusion Criteria (Staff):
- Work within a residential care facility participating in the study
- Speak and read English
- Able to provide own transportation to and from interviews with residents
- Inclusion Criteria (Residents
- Must reside within a participating residential care facility
- Must be at least 55 years of Age
- Must speak and read English
- Have a Dementia diagnosis
- Have a Score of at least 15 on the Mini Mental State Examination
- Exclusion Criteria (Residents)
- Residents will be excluded from the study if they show signs of rapid cognitive decline or physical deterioration over the last 6 months, as evidence by information gained during screening.
Exclusion
Key Trial Info
Start Date :
March 22 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2024
Estimated Enrollment :
234 Patients enrolled
Trial Details
Trial ID
NCT04769466
Start Date
March 22 2022
End Date
April 30 2024
Last Update
October 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Benjamin Rose Institute on Aging
Cleveland, Ohio, United States, 44120